Atara Biotherapeutics, Inc.
NASDAQ:ATRABiotechnology
Healthcare
$6.77 +1.96%
+$0.19 today
- Market cap
- $68.98M
- Beta
- 0.11
- P/E (TTM)
- -14.7
- EPS (TTM)
- -$0.67
52W Low $3.92High $19.15
Volume 0.02M
Average 1.40M
Price history
Atara Biotherapeutics, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
-49.70%
Period high
$18.09
Period low
$4.18
Latest
$6.77
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| S-3 | Nov 10, 2026 | Nov 10, 2026 | |
| 8-K | Nov 10, 2026 | Nov 10, 2026 | |
| 10-Q | Nov 10, 2026 | Nov 10, 2026 | |
| 4 | Sep 4, 2026 | Sep 4, 2026 | |
| 4 | Aug 26, 2026 | Aug 26, 2026 | |
| SC 13G/A | Aug 14, 2026 | Aug 14, 2026 | |
| 10-Q | Aug 12, 2026 | Aug 12, 2026 | |
| 8-K | Aug 12, 2026 | Aug 12, 2026 | |
| SC 13D/A | Jul 24, 2026 | Jul 24, 2026 | |
| 4 | Jul 24, 2026 | Jul 24, 2026 | |
| 3 | Jul 6, 2026 | Jul 6, 2026 | |
| 8-K | Jun 26, 2026 | Jun 26, 2026 | |
| 3 | Jun 15, 2026 | Jun 15, 2026 | |
| 4 | Jun 15, 2026 | Jun 15, 2026 | |
| 8-K | Jun 12, 2026 | Jun 12, 2026 |
Competitors
Who does Atara Biotherapeutics, Inc. compete with?
Open similar companies to compare their filings and price history.
Questions
Filing questions
Common questions about ATRA's filings, answered from its disclosures.
What is the latest ATRA filing?
The latest filing shown is S-3 dated Nov 10, 2026.
How many recent filings does ATRA have?
Intrinsic Alpha currently shows 20 recent filings for ATRA.
Continue the stock analysis
Jump to another research area for this company.